SCHEMBL30692003

SCHEMBL30692003

COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CCCC4)cc3)c2cc1OC

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 12/20 0.93
MET P08581 11/20 0.93
AURKB Q96GD4 4/20 0.93
KDR P35968 4/20 0.93
MERTK Q12866 3/20 0.93
FLT1 P17948 3/20 0.93
FLT3 P36888 2/20 0.93
AURKA O14965 1/20 0.93
RIPK2 O43353 1/20 0.93
ABCB11 O95342 1/20 0.93
ABL1 P00519 1/20 0.93
EGFR P00533 1/20 0.93
ERBB2 P04626 1/20 0.93
NTRK1 P04629 1/20 0.93
LCK P06239 1/20 0.93
PGR P06401 1/20 0.93
LYN P07948 1/20 0.93
RET P07949 1/20 0.93
CHRM2 P08172 1/20 0.93
HCK P08631 1/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cabozantinib SCHEMBL29351408 0.96 AXL (1.00) AXLMETAURKBKDRMERTK
Cabozantinib SCHEMBL29728791 0.96 AXL (1.00) AXLMETAURKBKDRMERTK
Cabozantinib SCHEMBL360795 0.96 AXL (1.00) AXLMETAURKBKDRMERTK
Cabozantinib SCHEMBL18095042 0.95 AXL (0.98) AXLMETAURKBKDRMERTK
Cabozantinib SCHEMBL18097906 0.94 AXL (0.94) AXLMETAURKBKDRMERTK
Cabozantinib SCHEMBL18095040 0.93 AXL (0.93) AXLMETAURKBKDRMERTK
Cabozantinib SCHEMBL29195419 0.92 AXL (0.91) AXLMETAURKBKDRMERTK
SCHEMBL15872120 0.91 AXL (0.90) AXLMETAURKBKDRMERTK
SCHEMBL30918289 0.91 AXL (0.90) AXLMETAURKBKDRMERTK
Cabozantinib SCHEMBL18097904 0.91 AXL (0.90) AXLMETAURKBKDRMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120447-A Cyclic compounds and methods of use thereof 薛定谔公司 2023-11-24 CN disclosed